c-Rel Antibody

Product Discontinued

c-Rel Antibody Summary

• Immunogen: The antiserum was produced against synthesized peptide derived from human Rel. The immunogen region is: C-terminal.
• Specificity: Rel (Ab-503) Antibody detects endogenous levels of total Rel protein.
• Clonality: Polyclonal
• Host: Rabbit
• Gene: REL
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:20000
  • Immunohistochemistry 1:50-1:100
  • Immunohistochemistry-Paraffin 1:50-1:100
  • Western Blot 1:500-1:1000

Reactivity Notes

Human

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS (without Mg2+ and Ca2+, pH 7.4), 0.15M NaCl and 50% Glycerol
• Preservative: 0.02% Sodium Azide
• Concentration: 1 mg/ml
• Purity: Immunogen affinity purified

Alternate Names for c-Rel Antibody

• C-Rel proto-oncogene protein
• cRel
• c-Rel
• I-Rel
• oncogene REL, avian reticuloendotheliosis
• proto-oncogene c-Rel
• REL
• v-rel avian reticuloendotheliosis viral oncogene homolog
• v-rel reticuloendotheliosis viral oncogene homolog (avian)

Background

c Rel is a protooncogene encoding a subunit of the NF kappa B family of transcription factors. In B and T cells, it is involved in the regulation of genes controlling cell division and immune function.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: REL
• Uniprot:
  • Q04864(Human)